Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

After much controversy, UK Govt has accepted India manufactured&nbsp;Covishield&nbsp;as an approved vaccine.
The updated guidelines by the&nbsp;UK state, "Formulations of the four listed vaccines, such as AstraZeneca Covishield, AstraZeneca Vaxzevria and Modern Takeda, qualify as approved vaccines."
The expanded list of accepted vaccines come into force from October 4. The travellers however must have finished the 2 dose course at least 14 days prior to travel.&nbsp;
Reports however indicate the reason behind Serum produced Covishield&nbsp;being left out of the 'accepted' list was due to the UK government raising doubts on the CoWin certification process and not due to any production quality concerns.&nbsp;&nbsp;
Adar Poonawalla, CEO of the world's largest vaccine producer Serum appealed to global leaders to harmonise vaccine certification on priority.
Poonawalla&nbsp;was quoted as saying&nbsp;&ldquo;It is not regulatory filing or quality systems but vaccine certificate systems that western nations are struggling to find a way out."

UK to allow travellers vaccinated with Covishield from Oct 4

After much controversy, UK Govt has accepted India manufactured&nbsp;Covishield&nbsp;as an approved vaccine.

"Formulations of the four listed vaccines, such as AstraZeneca Covishield, AstraZeneca Vaxzevria and Modern Takeda, qualify as approved vaccines."

After much controversy, UK Govt has accepted India manufactured&nbsp;Covishield&nbsp;as an approved vaccine.
The updated guidelines by the&nbsp;UK state, "Formulations of the four listed vaccines, such as AstraZeneca Covishield, AstraZeneca Vaxzevria and Modern Takeda, qualify as approved vaccines."
The expanded list of accepted vaccines come into force from October 4. The travellers however must have finished the 2 dose course at least 14 days prior to travel.&nbsp;
Reports however indicate the reason behind Serum produced Covishield&nbsp;being left out of the 'accepted' list was due to the UK government raising doubts on the CoWin certification process and not due to any production quality concerns.&nbsp;&nbsp;
Adar Poonawalla, CEO of the world's largest vaccine producer Serum appealed to global leaders to harmonise vaccine certification on priority.
Poonawalla&nbsp;was quoted as saying&nbsp;&ldquo;It is not regulatory filing or quality systems but vaccine certificate systems that western nations are struggling to find a way out."

As India touches the 600 million vaccine doses mark, the big question is how long it will take to vaccinate all adults. In this exclusive interview,  Dr. NK Arora, the (

On News Guru| What is the vaccine scale up plan looking like?

As India touches the 600 million vaccine doses mark, the big question is how long it will take to vaccinate all adults. In this exclusive interview,&nbsp;&nbsp;Dr. NK Arora,&nbsp;Chairman of the National Technical Advisory Group on Immunization in India&nbsp;gives us a month by month breakdown of the vaccine ramp up plan. He says that India can expect 200 million shots in September, and 300 shots a month from October onwards.&nbsp;

<div>
<div>How many doses can India administer till December?&nbsp;</div>
</div>

As India touches the 600 million vaccine doses mark, the big question is how long it will take to vaccinate all adults. In this exclusive interview,&nbsp;&nbsp;Dr. NK Arora,&nbsp;Chairman of the National Technical Advisory Group on Immunization in India&nbsp;gives us a month by month breakdown of the vaccine ramp up plan. He says that India can expect 200 million shots in September, and 300 shots a month from October onwards.&nbsp;

Austria, Germany, Slovenia, Greece, Iceland, Ireland and Spain are the seven EU member countries that accepted Covidshield vaccine on Thursday.

Covishield cleared by 8 EU nations for 'Green Pass'

Austria, Germany, Slovenia, Greece, Iceland, Ireland and Spain are the EU member countries that accepted Covishield vaccine on Thursday.

Covid-19: 8 European countries include Covishield in 'green pass'
India-made Covishield vaccine gets &lsquo;green pass&rsquo; in few European countries EU nations add SII&rsquo;s Covishield in Green Passport List
India reached out to EU for exemption on India-made vaccines

Austria, Germany, Slovenia, Greece, Iceland, Ireland and Spain are the EU member countries that accepted Covishield vaccine on Thursday.

Day after India formally requested European Union member states to include both Covishield&nbsp;and Covaxin&nbsp;in their exemption list for the passport, Switzerland and seven EU countries have added the Serum Institute-manufactured Oxford-Astrazeneca vaccine.
Austria, Germany, Slovenia, Greece, Iceland, Ireland and Spain are the seven EU member countries that accepted Covishield&nbsp;vaccine on Thursday. Earlier,&nbsp;India had reached out to member countries of the European Union, urging to list domestically-made coronavirus&nbsp;vaccines--Covaxin and&nbsp;Covishield on the national travel lists formed in the backdrop of the Covid crisis.&nbsp;

serum covishield

Categories